NCT04144153

Opioid Free Anesthesia and Bariatric Surgery

Opioid Free Total Intravenous Anesthesia Within an Enhanced Recovery After Surgery Pathway for Bariatric Surgery: A Randomized Controlled Clinical Trial

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 58 (actual)
• Sponsor: Northwell Health · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The morbidly obese bariatric surgery population is susceptible to opioid-induced complications such as respiratory depression and postoperative nausea and vomiting. This population may in particular benefit from opioid-sparing or opioid-free anesthetic techniques. This study aims to evaluate the effect of opioid free total intravenous anesthesia on postoperative quality of recovery in patients undergoing bariatric surgery.

Conditions

• Postoperative Quality of Recovery

Interventions

Type	Name	Description
COMBINATION_PRODUCT	Opioid Free Total Intravenous Anesthesia	Total intravenous anesthesia with propofol and dexmedetomidine hydrochloride and ketamine hydrochloride
COMBINATION_PRODUCT	Total Intravenous anesthesia with opioid	Total Intravenous anesthesia with opioid

Timeline

• Start date: 2021-08-09
• Primary completion: 2023-09-01
• Completion: 2023-09-01
• First posted: 2019-10-30
• Last updated: 2024-09-19

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study